Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Adarsh Dharmaraj"'
Autor:
Avaronnan Manuprasad, Praveen Kumar Shenoy, Joneetha Jones, N V Vinin, Adarsh Dharmaraj, Geetha Muttath
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 2, Pp 402-403 (2020)
Externí odkaz:
https://doaj.org/article/41307b415fb04b27ab7a38e67e6d3535
Autor:
Joneetha Jones, Adarsh Dharmaraj, PraveenKumar Shenoy, Avaronnan Manuprasad, Vinin Nv, Geetha Muttath
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 2, Pp 402-403 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423d515c74d1dbdeb53b3fbdf2865f6f
https://doi.org/10.4103/crst.crst_98_20
https://doi.org/10.4103/crst.crst_98_20
Autor:
Avaronnan Manuprasad, Praveen Kumar Shenoy, Joneetha Jones, N V Vinin, Adarsh Dharmarajan, Geetha Muttath
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 69-73 (2020)
Introduction: Majority of the patients in low-to-middle income countries (LMICs) have no access to adjuvant trastuzumab due to financial constraints. Short-course (9 weeks) schedule of trastuzumab is a feasible alternative in this setting. The object
Externí odkaz:
https://doaj.org/article/cc2c694ac2394807abdbb95d21bb487d